2026 BD opportunity scan for Hyperway Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rati

2026 BD opportunity scan for HUTCHMED (China) Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Hunan Zhengtai Jinhu Pharmaceutical Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou

2026 BD opportunity scan for Hunan Kelun Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r

2026 BD opportunity scan for Hope Medicine (Nanjing) Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rati

2026 BD opportunity scan for Hoffmann-La Roche Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for HJ Science Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Hisamitsu Pharmaceutical Co., Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rat

2026 BD opportunity scan for HighField Biopharmaceuticals, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rat

2026 BD opportunity scan for Help Therapeutics Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for HeiLongJiang ZBD Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Heilongjiang Kuihua Pharmaceutical Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and out